ハリガイ マサヨシ
HARIGAI MASAYOSHI
針谷 正祥 所属 医学部 医学科(東京女子医科大学病院) 職種 教授・基幹分野長 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry. |
掲載誌名 | 正式名:Arthritis research & therapy 略 称:Arthritis Res Ther ISSNコード:(1478-6362)1478-6354(Linking) |
掲載区分 | 国外 |
巻・号・頁 | 17,pp.74 |
著者・共著者 | Sakai Ryoko, Cho Soo-Kyung, Nanki Toshihiro, Watanabe Kaori, Yamazaki Hayato, Tanaka Michi, Koike Ryuji, Tanaka Yoshiya, Saito Kazuyoshi, Hirata Shintaro, Amano Koichi, Nagasawa Hayato, Sumida Takayuki, Hayashi Taichi, Sugihara Takahiko, Dobashi Hiroaki, Yasuda Shinsuke, Sawada Tetsuji, Ezawa Kazuhiko, Ueda Atsuhisa, Fujii Takao, Migita Kiyoshi, Miyasaka Nobuyuki, Harigai Masayoshi, |
発行年月 | 2015/03 |
概要 | The adjusted risks for SAEs and SIs were not significantly different between TCZ and TNFIs, indicating an influence of clinical characteristics of the patients on the safety profile of the biologics in clinical practice. |
DOI | 10.1186/s13075-015-0583-8 |
PMID | 25880658 |